|

Liver Disease Clinical Trials in Arkansas

16 recruiting studies across 5 cities

All Trials in Arkansas

Phase
Trial Phase Location
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHPhase 3Conway
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Phase 3Conway
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)—Fort Smith
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 2Fort Smith
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisPhase 3Little Rock
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHPhase 3Little Rock
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Phase 3Little Rock
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)Phase 2Little Rock
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHPhase 3Little Rock
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Phase 3Little Rock
A Trial of Inebilizumab in Participants With Autoimmune HepatitisPhase 3Little Rock
Functional Assessment in Liver Transplantation—Little Rock
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/ALittle Rock
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Little Rock
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)N/ALittle Rock
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Phase 3North Little Rock

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.